Heart Rhythm
Volume 5, Issue 5 , Pages 734-741, May 2008

Computational analysis of the effects of the hERG channel opener NS1643 in a human ventricular cell model

  • Torben Peitersen, MSc

      Affiliations

    • Danish National Research Foundation Centre for Cardiac Arrhythmia, Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
  • ,
  • Morten Grunnet, PhD

      Affiliations

    • Danish National Research Foundation Centre for Cardiac Arrhythmia, Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    • NeuroSearch A/S, Ballerup, Denmark.
  • ,
  • Alan P. Benson, PhD

      Affiliations

    • Computational Biology Laboratory, Institute of Membrane and Systems Biology, University of Leeds, Leeds, United Kingdom
  • ,
  • Arun V. Holden, PhD

      Affiliations

    • Computational Biology Laboratory, Institute of Membrane and Systems Biology, University of Leeds, Leeds, United Kingdom
  • ,
  • Niels-Henrik Holstein-Rathlou, MD, PhD

      Affiliations

    • Danish National Research Foundation Centre for Cardiac Arrhythmia, Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
  • ,
  • Søren-Peter Olesen, MD, PhD

      Affiliations

    • Danish National Research Foundation Centre for Cardiac Arrhythmia, Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark
    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Søren-Peter Olesen, Department of Biomedical Sciences, The Panum Institute, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.

Received 30 November 2007; accepted 23 February 2008. published online 28 February 2008.

Background

Dysfunction or pharmacologic inhibition of repolarizing cardiac ionic currents can lead to fatal arrhythmias. The hERG potassium channel underlies the repolarizing current IKr, and mutations therein can produce both long and short QT syndromes (LQT2 and SQT1). We previously reported on the diphenylurea compound NS1643, which acts on hERG channels in two distinct ways: by increasing overall conductance and by shifting the inactivation curve in the depolarized direction.

Objective

The purpose of this study was to determine which of the two components contributes more to the antiarrhythmic effects of NS1643 under normokalemic and hypokalemic conditions.

Methods

The study consisted of mathematical simulation of action potentials in a human ventricular ionic cell model in single cell and string of 100 cells.

Results

Regardless of external potassium concentration or diastolic interval used, NS1643 decreases action potential duration and triangulation. For single cells, NS1643 increases the postrepolarization refractory time but shortens the absolute refractory period. In one dimensional simulations, NS1643 increases the vulnerable window for unidirectional block but suppresses the emergence of premature action potentials and unidirectional blocks around APD90. During normokalemia, shifting the inactivation curve has greater impact than increasing conductance, whereas the opposite occurs during hypokalemia.

Conclusion

Increased hERG conductance and the depolarizing shift of the inactivation curve both contribute to the antiarrhythmic actions of NS1643, with relative effects dependent on external K+ concentration.

Keywords: Action potential, Ion channel, Delayed rectifier, Early afterdepolarization, Long QT syndrome

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The work was supported by the Danish National Research Foundation to Drs. Holstein-Rathlou, Olesen, Peitersen, and Grunnet; The Medical Research Council, UK to Dr. Benson; and The European Union through the Network of Excellence BioSim, Contract No. LHSB-CT-2004-005137, to Drs. Holden, Benson, Holstein-Rathlou, and Peitersen. Dr. Grunnet is an employee of NeuroSearch and Dr. Olesen is consultant to the company, which owns the rights to the compound NS1643.

PII: S1547-5271(08)00207-5

doi:10.1016/j.hrthm.2008.02.026

Heart Rhythm
Volume 5, Issue 5 , Pages 734-741, May 2008